Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J AITCHISON

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Psychological Medicine|October 30, 2009
Trajectories of change in depression severity during treatment with antidepressantsR Uher, B Muthén, D Souery, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 7, 2015
Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorderRebecca MacGregor Legge, Shahbaz Sendi, James H Cole, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 31, 2019
Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorderOle Köhler-Forsberg, Erik Roj Larsen, Henriette N Buttenschøn, et al.
Plos One|September 21, 2016
Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot StudyAntonella Trotta, Conrad Iyegbe, Marta Di Forti, et al.
Psychological Medicine|September 21, 2011
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptomsR Uher, R H Perlis, N Henigsberg, et al.
Pharmacogenetics|February 24, 2001
Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significanceK J Aitchison, F J Gonzalez, L C Quattrochi, et al.
Journal of Affective Disorders|March 18, 2011
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptylineRudolf Uher, Mojca Zvezdana Dernovsek, Ole Mors, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 8, 2012
Ethnic variations in pathways into early intervention services for psychosisSharif Ghali, Helen L Fisher, John Joyce, et al.
Brain, Behavior, and Immunity|March 5, 2017
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depressionOle Köhler-Forsberg, Henriette N Buttenschøn, Katherine E Tansey, et al.
The Journal of Clinical Psychiatry|June 16, 2011
Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volumeValeria Mondelli, Annamaria Cattaneo, Martino Belvederi Murri, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Psychological Medicine|October 30, 2009
Trajectories of change in depression severity during treatment with antidepressantsR Uher, B Muthén, D Souery, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 7, 2015
Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorderRebecca MacGregor Legge, Shahbaz Sendi, James H Cole, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 31, 2019
Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorderOle Köhler-Forsberg, Erik Roj Larsen, Henriette N Buttenschøn, et al.
Plos One|September 21, 2016
Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot StudyAntonella Trotta, Conrad Iyegbe, Marta Di Forti, et al.
Psychological Medicine|September 21, 2011
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptomsR Uher, R H Perlis, N Henigsberg, et al.
Pharmacogenetics|February 24, 2001
Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significanceK J Aitchison, F J Gonzalez, L C Quattrochi, et al.
Journal of Affective Disorders|March 18, 2011
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptylineRudolf Uher, Mojca Zvezdana Dernovsek, Ole Mors, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 8, 2012
Ethnic variations in pathways into early intervention services for psychosisSharif Ghali, Helen L Fisher, John Joyce, et al.
Brain, Behavior, and Immunity|March 5, 2017
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depressionOle Köhler-Forsberg, Henriette N Buttenschøn, Katherine E Tansey, et al.
The Journal of Clinical Psychiatry|June 16, 2011
Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volumeValeria Mondelli, Annamaria Cattaneo, Martino Belvederi Murri, et al.
Pageof 18